0

Global Urinary Incontinence Therapeutics Market 2019-2023

  • Published: Oct 2018
  • Pages: 116
  • SKU: IRTNTR30102
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global urinary incontinence therapeutics market is predicted to grow considerably by 2023 fueled by the rising incidences of urinary incontinence in men and women across the globe. Wondering how to make the most of this thriving urinary incontinence therapeutics industry? Technavio’s extensive industry research report offers a detailed insight that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the global urinary incontinence therapeutics market. It also examines the competitive landscape and some key companies that include Allergan, Astellas Pharma, and Merck.

Let's dissect the latest facts about the urinary incontinence therapeutics industry

The global urinary incontinence therapeutics market is expected to grow at a CAGR of more than 3% during the forecast

Urinary incontinence therapeutics industry growth is expected to accelerate massively over the next five years driven by the robust pipeline for the development of drugs for urinary incontinence treatment. Most of the urinary incontinence therapeutics that are currently in Phase III stage are likely to get approved during the forecast period to augment the growth of the global urinary incontinence therapeutics market. Furthermore, the increasing number of molecules being developed for urinary incontinence treatment will drive the demand for urinary incontinence therapeutics across the period of forecast. Technavio's urinary incontinence therapeutics industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

The Americas will be the largest driver of growth for the global urinary incontinence therapeutics market

More than half of the incremental growth of the global urinary incontinence therapeutics market will be driven by the Americas during the forecast period, while EMEA and APAC are predicted to make sizeable contributions to the market growth. The Americas also held the largest share of around 52% in the global urinary incontinence therapeutics market, followed by EMEA and APAC respectively. However, APAC is forecasted to generate the fastest rate of growth in the global urinary incontinence therapeutics market over the next five years while the Americas will register a higher CAGR than EMEA during the same period.

Get more value with Technavio's subscription platform! Gain easy access to all Technavio's reports, along with on-demand services. Start your 14-day FREE trial

 

Allergan, Astellas Pharma, and Merck are among the leading vendors in the urinary incontinence therapeutics market

The global urinary incontinence therapeutics market is slated to become reasonably fragmented with the presence of several vendors who offer products for treatment for all types of urinary incontinence. Urinary incontinence is a widespread urological disorder affecting more than 200 million people worldwide and around 17 million people in the US. Many international and regional vendors are vying for their share of the global urinary incontinence therapeutics market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

  • Allergan
  • Astellas Pharma
  • Merck
  • Novartis
  • Pfizer

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch

 

 

Read More Read Less

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Anticholinergic drugs - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13:  VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Astellas Pharma
  • Merck
  • Novartis
  • Pfizer

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations

PART 15: EXPLORE TECHNAVIO

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>